- Home
- WULF vs ARQT Comparison
WULF vs ARQT Comparison
Compare WULF & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- ARQT
- Stock Information
- Founded
- WULF 1952
- ARQT 2016
- Country
- WULF United States
- ARQT United States
- Employees
- WULF N/A
- ARQT N/A
- Industry
- WULF EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- WULF Technology
- ARQT Health Care
- Exchange
- WULF Nasdaq
- ARQT Nasdaq
- Market Cap
- WULF 1.8B
- ARQT 1.7B
- IPO Year
- WULF 1995
- ARQT 2020
- Fundamental
- Price
- WULF $5.13
- ARQT $14.61
- Analyst Decision
- WULF Strong Buy
- ARQT Strong Buy
- Analyst Count
- WULF 8
- ARQT 6
- Target Price
- WULF $8.44
- ARQT $18.80
- AVG Volume (30 Days)
- WULF 56.3M
- ARQT 1.8M
- Earning Date
- WULF 08-11-2025
- ARQT 08-13-2025
- Dividend Yield
- WULF N/A
- ARQT N/A
- EPS Growth
- WULF N/A
- ARQT N/A
- EPS
- WULF N/A
- ARQT N/A
- Revenue
- WULF $132,023,000.00
- ARQT $212,819,000.00
- Revenue This Year
- WULF $45.98
- ARQT $61.01
- Revenue Next Year
- WULF $83.67
- ARQT $37.95
- P/E Ratio
- WULF N/A
- ARQT N/A
- Revenue Growth
- WULF 31.85
- ARQT 100.03
- 52 Week Low
- WULF $2.06
- ARQT $7.86
- 52 Week High
- WULF $9.30
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- WULF 58.66
- ARQT 62.42
- Support Level
- WULF $4.82
- ARQT $15.00
- Resistance Level
- WULF $5.34
- ARQT $15.97
- Average True Range (ATR)
- WULF 0.40
- ARQT 0.66
- MACD
- WULF 0.02
- ARQT 0.16
- Stochastic Oscillator
- WULF 64.29
- ARQT 85.37
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.